Evidence map›Paper›PMID 37022597›Full record

ArticleMolecular biotechnology2023

Murine Cytomegalovirus Infection Induced miR-1929-3p Down-Regulation Promotes the Proliferation and Apoptosis of Vascular Smooth Muscle Cells in Mice by Targeting Endothelin A Receptor and Downstream NLRP3 Activation Pathway.

Lijuan He, Wei Zhou, Lamei Wang, Na Tang, Yongjia Wang, Hua Zhong, Yan Tang, Dongmei Xi, Fang He

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lijuan He *NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases and Key Laboratory of Education Ministry of Xinjiang Endemic and Ethnic Diseases, Medical College of Shihezi University, 59 North 2Nd Road, Shihezi, 832002, Xinjiang, People's Republic of China.
Wei Zhou *NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases and Key Laboratory of Education Ministry of Xinjiang Endemic and Ethnic Diseases, Medical College of Shihezi University, 59 North 2Nd Road, Shihezi, 832002, Xinjiang, People's Republic of China.
Lamei Wang *Centre of Medical Functional Experiments, Medical College of Shihezi University, Shihezi, 832002, People's Republic of China.
Na TangNHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases and Key Laboratory of Education Ministry of Xinjiang Endemic and Ethnic Diseases, Medical College of Shihezi University, 59 North 2Nd Road, Shihezi, 832002, Xinjiang, People's Republic of China.
Yongjia WangNHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases and Key Laboratory of Education Ministry of Xinjiang Endemic and Ethnic Diseases, Medical College of Shihezi University, 59 North 2Nd Road, Shihezi, 832002, Xinjiang, People's Republic of China.
Hua ZhongNHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases and Key Laboratory of Education Ministry of Xinjiang Endemic and Ethnic Diseases, Medical College of Shihezi University, 59 North 2Nd Road, Shihezi, 832002, Xinjiang, People's Republic of China.
Yan TangDepartment of Geriatrics, The First Affiliated Hospital of Medical College of Shihezi University, Shihezi, 832002, People's Republic of China.
Dongmei XiNHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases and Key Laboratory of Education Ministry of Xinjiang Endemic and Ethnic Diseases, Medical College of Shihezi University, 59 North 2Nd Road, Shihezi, 832002, Xinjiang, People's Republic of China. 1047719655@qq.com.ORCID 0000-0002-1009-363X
Fang HeNHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases and Key Laboratory of Education Ministry of Xinjiang Endemic and Ethnic Diseases, Medical College of Shihezi University, 59 North 2Nd Road, Shihezi, 832002, Xinjiang, People's Republic of China. fangf2002shz@126.com.ORCID 0000-0001-6912-6187
Shihezi University · CNFirst Affiliated Hospital of Shihezi University Medical College · CN

Funding

"3152" project of Shihezi University ZG010308National College Students Innovation and Entrepreneurship Training Program 202010759027National Natural Science Foundation of China 31960187Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2020-PT330-003Scientific research project of Shihezi University NO. ZZZC201921AYouth Innovation and Talent Cultivation Project of shihezi university CXPY202216
6 · The paper itself

Abstract

Our previous study demonstrated in vivo that mouse cytomegalovirus (MCMV) infection promoted vascular remodeling after downregulation of miR-1929-3p. This study aimed to investigate the role of miR-1929-3p/ETAR/NLRP3 pathway in mouse vascular smooth muscle cells (MOVAS) after MCMV infection. First, PCR was used to detect the success of the infection. Second, MOVAS were transfected with the miR-1929-3p mimic, inhibitor, and ETAR overexpressed adenovirus vector. Cell proliferation was detected using EdU, whereas apoptosis was detected using flow cytometry. The expression of miR-1929-3p and ETAR were detected using qRT-PCR. Western blot detected proteins of cell proliferation, apoptosis, and the NLRP3 inflammasome. Interleukin-1β and interleukin-18 were determined using ELISA. The results revealed that after 48 h, MCMV infection promoted the proliferation of MOVAS when the MOI was 0.01. MCMV infection increased ETAR by downregulating miR-1929-3p. The miR-1929-3p mimic reversed the proliferation and apoptosis, whereas the miR-1929-3p inhibitor promoted this effect. ETAR overexpression further promoted MCMV infection by downregulating miR-1929-3p-mediated proliferation and apoptosis. MCMV infection mediates the downregulation of miR-1929-3p and the upregulation of ETAR, which activates NLRP3 inflammasome. In conclusion, MCMV infection promoted the proliferation of MOVAS, possibly by downregulating miR-1929-3p, promoting the upregulation of the target gene ETAR and activating NLRP3 inflammasome.

Indexed as

Cytomegalovirus InfectionsMicroRNAsMuromegalovirusAnimalsApoptosisCell ProliferationDown-RegulationInflammasomesMiceMuscle, Smooth, VascularNLR Family, Pyrin Domain-Containing 3 ProteinReceptor, Endothelin AInflammasomesMicroRNAsNLR Family, Pyrin Domain-Containing 3 ProteinReceptor, Endothelin AEndothelin receptor type AmiR-1929-3pMurine cytomegalovirusNLRP3 inflammasomeVascular smooth muscle cell

Identifiers

PMID37022597
OpenAlexW4362658348

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.